Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

VAV1 degrader-3

😃Good
Catalog No. T201392Cas No. 3050683-38-7

VAV1 degrader-3 is a molecular gel degrader targeting VAV1 with a DC50 of 7 nM. VAV1 is a key signaling protein downstream of T cell and B cell receptors. VAV1 degrades VAV1 to degrader-3, which significantly reduces the level of cytokines associated with immune-mediated diseases, but has no effect on other proteins, and can be used to study inflammatory or autoimmune diseases.In mouse models of various diseases, such as experimental autoimmune encephalomyelitis (EAE), colitis, and collagen-induced arthritis (CIA), VAV1 degraders the progression of disease.

VAV1 degrader-3

VAV1 degrader-3

😃Good
Catalog No. T201392Cas No. 3050683-38-7
VAV1 degrader-3 is a molecular gel degrader targeting VAV1 with a DC50 of 7 nM. VAV1 is a key signaling protein downstream of T cell and B cell receptors. VAV1 degrades VAV1 to degrader-3, which significantly reduces the level of cytokines associated with immune-mediated diseases, but has no effect on other proteins, and can be used to study inflammatory or autoimmune diseases.In mouse models of various diseases, such as experimental autoimmune encephalomyelitis (EAE), colitis, and collagen-induced arthritis (CIA), VAV1 degraders the progression of disease.
Pack SizePriceAvailabilityQuantity
1 mg$340Backorder
5 mg$970Backorder
25 mg$1,520Backorder
50 mg$1,980Backorder
Bulk & Custom
Add to Cart
Questions
View More
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
VAV1 degrader-3 is a molecular gel degrader targeting VAV1 with a DC50 of 7 nM. VAV1 is a key signaling protein downstream of T cell and B cell receptors. VAV1 degrades VAV1 to degrader-3, which significantly reduces the level of cytokines associated with immune-mediated diseases, but has no effect on other proteins, and can be used to study inflammatory or autoimmune diseases.In mouse models of various diseases, such as experimental autoimmune encephalomyelitis (EAE), colitis, and collagen-induced arthritis (CIA), VAV1 degraders the progression of disease.
In vitro
VAV1 degrader-3 (0-1μM, 24h) induces VAV1 degradation, thereby reducing CD69 expression mediated by the B cell receptor and the secretion of IL-6 and IgG in primary human B cells.
VAV1 degrader-3 inhibits the growth of B lymphoma cells in a concentration-dependent manner. [1]
In vivo
VAV1 degrader-3 (1-10 mg/kg, oral) inhibits the progression of experimental autoimmune encephalomyelitis (EAE) in the EAE mouse model in a dose-dependent manner.
In the T cell transfer-induced colitis model, VAV1 degrader-3 (1 mg/kg, oral) inhibited colitis.
In the collagen-induced arthritis model, VAV1 degrader-3 (1 mg/kg, 21 days, oral) reduced the production of anti-collagen II IgG1 antibodies and prevented the progression of arthritis. [1]
Chemical Properties
Molecular Weight392.83
FormulaC22H17ClN2O3
Cas No.3050683-38-7
Relative Density.no data available
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy VAV1 degrader-3 | purchase VAV1 degrader-3 | VAV1 degrader-3 cost | order VAV1 degrader-3 | VAV1 degrader-3 chemical structure | VAV1 degrader-3 in vivo | VAV1 degrader-3 in vitro | VAV1 degrader-3 formula | VAV1 degrader-3 molecular weight